- Presentations
- 7
- Markets
- 1
Rexulti is a brand of Brexpiprazole marketed by Otsuka America Pharmaceutical, with 7 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Brexpiprazole
- Brand owner
- Otsuka America Pharmaceutical
- Registered in
- United States
- Strengths and forms
- kit, 0.25 mg tablet, 0.5 mg tablet, 1 mg tablet, 2 mg tablet, 3 mg tablet, 4 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Rexulti kit | Otsuka America Pharmaceutical | US FDA | Available on request |
| Rexulti 0.25 mg tabletOral | Otsuka America Pharmaceutical | US FDA | Available on request |
| Rexulti 0.5 mg tabletOral | Otsuka America Pharmaceutical | US FDA | Available on request |
| Rexulti 1 mg tabletOral | Otsuka America Pharmaceutical | US FDA | Available on request |
| Rexulti 2 mg tabletOral | Otsuka America Pharmaceutical | US FDA | Available on request |
| Rexulti 3 mg tabletOral | Otsuka America Pharmaceutical | US FDA | Available on request |
| Rexulti 4 mg tabletOral | Otsuka America Pharmaceutical | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Rexulti
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.